# FrontView REIT, Inc.: filings

FVR · NYSE · CIK 1988494 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fvr.md) · [Financials](/companies/fvr/financials.md) · [Filings](/companies/fvr/filings.md) · [Insiders](/companies/fvr/insiders.md)

## Reports and events: 51 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 69, 8-K 37, 3 14, SCHEDULE 13G/A 14, CORRESP 7, SCHEDULE 13G 7, UPLOAD 7, 10-Q 6, DRS/A 5, DRSLTR 4, S-11/A 4, SC 13G 4, 424B5 3, 10-K 2, 4/A 2, 8-K/A 2, ARS 2, DEF 14A 2, DEFA14A 2, EFFECT 2, 3/A 1, 424B4 1, 8-A12B 1, CERT 1, D 1, DEL AM 1, DRS 1, FWP 1, S-11 1, S-3 1, S-8 1, SCHEDULE 13D 1, SCHEDULE 13D/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-19 | 16:30 ET | [8-K](/filings/0001193125-26-425299.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-425299 |
| 2026-10-16 | 16:30 ET | [SCHEDULE 13D/A](/filings/0001104659-26-116633.md) | Ownership report, active investor, amended | 0001104659-26-116633 |
| 2026-10-01 | 07:30 ET | [8-K](/filings/0001193125-26-409816.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-409816 |
| 2026-09-30 | 16:05 ET | [8-K](/filings/0001193125-26-409039.md) | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-26-409039 |
| 2026-09-14 | 07:15 ET | [8-K](/filings/0001193125-26-389835.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-389835 |
| 2026-08-19 | 16:35 ET | [8-K](/filings/0001193125-26-357004.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-357004 |
| 2026-08-06 | 16:54 ET | [10-Q](/filings/0001193125-26-338354.md) | Quarterly report, period 2026-06-30 | 0001193125-26-338354 |
| 2026-08-06 | 07:15 ET | [8-K](/filings/0001193125-26-336727.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-336727 |
| 2026-07-01 | 07:25 ET | [8-K](/filings/0001193125-26-291502.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-291502 |
| 2026-06-05 | 16:15 ET | [8-K/A](/filings/0001193125-26-259603.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-259603 |
| 2026-06-01 | 07:05 ET | [8-K](/filings/0001193125-26-249701.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-249701 |
| 2026-05-28 | 07:05 ET | [8-K](/filings/0001193125-26-242975.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-242975 |
| 2026-05-27 | 17:03 ET | [8-K](/filings/0001193125-26-242115.md) | 5.07 Shareholder vote results | 0001193125-26-242115 |
| 2026-05-07 | 16:06 ET | [10-Q](/filings/0001193125-26-211875.md) | Quarterly report, period 2026-03-31 | 0001193125-26-211875 |
| 2026-05-06 | 16:05 ET | [8-K](/filings/0001193125-26-208927.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-208927 |
| 2026-04-17 | 16:05 ET | [DEF 14A](/filings/0001193125-26-161511.md) | Proxy statement, period 2026-05-27 | 0001193125-26-161511 |
| 2026-04-06 | 16:31 ET | [SCHEDULE 13D](/filings/0001104659-26-039969.md) | Ownership report, active investor | 0001104659-26-039969 |
| 2026-04-06 | 16:05 ET | [8-K](/filings/0001193125-26-143712.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-143712 |
| 2026-02-27 | 17:25 ET | [8-K](/filings/0001193125-26-083249.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-083249 |
| 2026-02-27 | 21:08 ET | [8-K/A](/filings/0001193125-26-078473.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-26-078473 |
| 2026-02-25 | 17:28 ET | [10-K](/filings/0001193125-26-072181.md) | Annual report, period 2025-12-31 | 0001193125-26-072181 |
| 2026-02-24 | 16:10 ET | [8-K](/filings/0001193125-26-066990.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-066990 |
| 2026-02-12 | 16:15 ET | [8-K](/filings/0001193125-26-048763.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-048763 |
| 2026-01-12 | 16:15 ET | [8-K](/filings/0001193125-26-010397.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-010397 |
| 2025-11-18 | 17:11 ET | [8-K](/filings/0001193125-25-286433.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-286433 |
| 2025-11-13 | 16:10 ET | [10-Q](/filings/0001193125-25-280175.md) | Quarterly report, period 2025-09-30 | 0001193125-25-280175 |
| 2025-11-12 | 16:25 ET | [8-K](/filings/0001193125-25-277713.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-277713 |
| 2025-11-12 | 16:23 ET | [8-K](/filings/0001193125-25-277698.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-277698 |
| 2025-11-12 | 16:17 ET | [8-K](/filings/0001193125-25-277638.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-277638 |
| 2025-08-14 | 16:17 ET | [10-Q](/filings/0000950170-25-108893.md) | Quarterly report, period 2025-06-30 | 0000950170-25-108893 |
| 2025-08-13 | 16:15 ET | [8-K](/filings/0000950170-25-108040.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-108040 |
| 2025-08-13 | 16:14 ET | [8-K](/filings/0000950170-25-108037.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-108037 |
| 2025-06-30 | 16:15 ET | [8-K](/filings/0000950170-25-091586.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-091586 |
| 2025-06-16 | 17:30 ET | [8-K](/filings/0000950170-25-086892.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-086892 |
| 2025-05-29 | 16:30 ET | [8-K](/filings/0000950170-25-079015.md) | 5.07 Shareholder vote results | 0000950170-25-079015 |
| 2025-05-15 | 16:36 ET | [10-Q](/filings/0000950170-25-072774.md) | Quarterly report, period 2025-03-31 | 0000950170-25-072774 |
| 2025-05-15 | 16:00 ET | [8-K](/filings/0000950170-25-072541.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-072541 |
| 2025-05-14 | 16:30 ET | [8-K](/filings/0000950170-25-071499.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-071499 |
| 2025-04-30 | 16:15 ET | [8-K](/filings/0000950170-25-061066.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-061066 |
| 2025-04-17 | 17:00 ET | [DEF 14A](/filings/0000950170-25-055535.md) | Proxy statement, period 2025-05-27 | 0000950170-25-055535 |
| 2025-04-16 | 09:43 ET | [8-K](/filings/0000950170-25-054510.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-054510 |
| 2025-03-24 | 16:20 ET | [8-K](/filings/0000950170-25-043860.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-043860 |
| 2025-03-20 | 17:21 ET | [10-K](/filings/0000950170-25-042774.md) | Annual report, period 2024-12-31 | 0000950170-25-042774 |
| 2025-03-20 | 18:15 ET | [8-K](/filings/0000950170-25-042222.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-042222 |
| 2025-02-27 | 17:12 ET | [8-K](/filings/0000950170-25-029229.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-029229 |
| 2025-01-10 | 16:00 ET | [8-K](/filings/0000950170-25-004128.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-004128 |
| 2024-11-18 | 16:54 ET | [8-K](/filings/0000950170-24-128052.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-128052 |
| 2024-11-14 | 16:30 ET | [10-Q](/filings/0000950170-24-127114.md) | Quarterly report, period 2024-09-30 | 0000950170-24-127114 |
| 2024-11-13 | 17:21 ET | [8-K](/filings/0000950170-24-126510.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-126510 |
| 2024-10-23 | 17:29 ET | [8-K](/filings/0000950170-24-116722.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-116722 |

Page 1 of 2. [Older](/companies/fvr/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 16:12 ET. No prices; not investment advice.